MTOR and inflammatory skin disease: Taken together, these findings strongly demonstrate the altered epidermal mTOR signaling status under skin inflammatory disease conditions and suggest that inhibition of mTOR signaling activity as a promising treatment for inflammatory skin disease in general (Karagianni et al., 2022).